These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 18982913)
1. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Vadivelu N; Hines RL Clin Interv Aging; 2008; 3(3):421-30. PubMed ID: 18982913 [TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
3. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain. Plosker GL Drugs; 2011 Dec; 71(18):2491-509. PubMed ID: 22141389 [TBL] [Abstract][Full Text] [Related]
4. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus. Pergolizzi JV; Mercadante S; Echaburu AV; Van den Eynden B; Fragoso RM; Mordarski S; Lybaert W; Beniak J; Orońska A; Slama O; Curr Med Res Opin; 2009 Jun; 25(6):1517-28. PubMed ID: 19435402 [TBL] [Abstract][Full Text] [Related]
5. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Kress HG Eur J Pain; 2009 Mar; 13(3):219-30. PubMed ID: 18567516 [TBL] [Abstract][Full Text] [Related]
6. Transdermal buprenorphine in cancer pain and palliative care. Sittl R Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218 [TBL] [Abstract][Full Text] [Related]
7. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients. Griessinger N; Sittl R; Likar R Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522 [TBL] [Abstract][Full Text] [Related]
8. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain. Mitra F; Chowdhury S; Shelley M; Williams G Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402 [TBL] [Abstract][Full Text] [Related]
9. Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age. Likar R; Vadlau EM; Breschan C; Kager I; Korak-Leiter M; Ziervogel G Clin J Pain; 2008; 24(6):536-43. PubMed ID: 18574363 [TBL] [Abstract][Full Text] [Related]
10. [Pain therapy in the elderly:7-day transdermal buprenorphine patch in clinical practice. Results of a non-interventional study]. Wahle K; Krings D; Schwenke K MMW Fortschr Med; 2013 Mar; 155 Suppl 1():25-31. PubMed ID: 23678668 [TBL] [Abstract][Full Text] [Related]
11. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials. Likar R; Kayser H; Sittl R Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176 [TBL] [Abstract][Full Text] [Related]
12. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison. Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542 [TBL] [Abstract][Full Text] [Related]
13. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies. Louis F Int J Clin Pract; 2006 Oct; 60(10):1330-4. PubMed ID: 16981980 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Karlsson M; Berggren AC Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841 [TBL] [Abstract][Full Text] [Related]
15. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Sittl R; Griessinger N; Likar R Clin Ther; 2003 Jan; 25(1):150-68. PubMed ID: 12637117 [TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and safety of transdermal buprenorphine for chronic pain treatment in the elderly: a prospective observational study]. Muriel Villoria C; Pérez-Castejón Garrote JM; Sánchez Magro I; Neira Alvarez M Med Clin (Barc); 2007 Feb; 128(6):204-10. PubMed ID: 17335723 [TBL] [Abstract][Full Text] [Related]
17. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain]. Tschirner M; Ritzdorf I; Brünjes R MMW Fortschr Med; 2008 Sep; 150 Suppl 3():142-8. PubMed ID: 19025217 [TBL] [Abstract][Full Text] [Related]
18. [Transdermal buprenorphine: a current overview of pharmacological and clinical data]. Faymonville ME; Libbrecht D Rev Med Liege; 2008 Nov; 63(11):671-6. PubMed ID: 19112993 [TBL] [Abstract][Full Text] [Related]
19. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study. Sorge J; Sittl R Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693 [TBL] [Abstract][Full Text] [Related]
20. Transdermal buprenorphine for the treatment of chronic noncancer pain in the oldest old. Gianni W; Madaio AR; Ceci M; Benincasa E; Conati G; Franchi F; Galetti G; Nieddu A; Salani B; Zuccaro SM J Pain Symptom Manage; 2011 Apr; 41(4):707-14. PubMed ID: 21145700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]